Detalles de la búsqueda
1.
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.
Cancer Cell Int
; 19: 83, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992690
2.
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Haematologica
; 103(6): 1029-1037, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567768
3.
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.
Diagnostics (Basel)
; 12(6)2022 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35741115
4.
Increased values of the circulating PDGFß sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia.
Blood Cells Mol Dis
; 55(3): 211-2, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26227847
5.
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
Hematol Oncol
; 33(4): 250-2, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25256816
6.
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
Front Oncol
; 10: 1428, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014780
7.
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.
Cancers (Basel)
; 12(7)2020 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629801
8.
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
Front Oncol
; 9: 528, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293969
9.
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
Front Oncol
; 9: 532, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293972
10.
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation.
Leuk Res
; 70: 20-24, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747074
11.
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Front Oncol
; 8: 555, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30574454
12.
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
Leuk Lymphoma
; 48(8): 1502-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17701580
13.
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Oncotarget
; 8(45): 79188-79200, 2017 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108298
14.
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
Front Pharmacol
; 8: 413, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28706485
15.
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
Cancer Chemother Pharmacol
; 79(4): 767-773, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28289867
16.
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
Oncotarget
; 8(50): 88021-88033, 2017 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29152138
17.
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.
Front Pharmacol
; 7: 363, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27790140
18.
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.
Br J Haematol
; 149(3): 451-4, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20085581
19.
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.
Leuk Res
; 29(8): 961-6, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15978948
20.
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment.
Cancer Genet Cytogenet
; 162(1): 57-62, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16157201